Lucknow Speciality Pharma

Lorlatinib Tablets 25 mg
Lorlatinib Tablets, Lorviqua is a cancer medicine used to treat adults with non-small cell lung cancer (NSCLC) when the disease is advanced and ALK-positive, which means that the cancer cells have certain changes affecting the gene responsible for a protein called ALK (anaplastic lymphoma kinase). To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Lorlatinib Tablets, on March 3, 2021, the Food and Drug Administration granted regular approval to lorlatinib (Lorbrena, Pfizer Inc.) for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive,  detected by an FDA-approved test.

Lorlatinib Tablets Available Price In Lucknow Banaras Nepal

Lorlatinib Tablets 

  • Innovator Brand Name – Ziagen
  • Generic Brand Available – Lorviqua
  • API – Lorlatinib
  • Packaging – 90 Tablets
  • Strength – 25 mg, 100 mg

What is Lorlatinib used for?

Lorlatinib Tablets is used to treat a certain type of lung cancer. It works by slowing or stopping the growth of cancer cells.

 

About Us

Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

Get Access To Lorlatinib Tablets 25 mg

Enter Buying Requirements Details

For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

FAQs – Medicine Questions

Lorlatinib Tablets 25 mg
What is lorlatinib used for?
Lorlatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will perform a test to check for the ALK gene before you use this medicine
How do you take lorlatinib?
Lorlatinib comes as a tablet to take by mouth. It is usually taken with or without food once daily. Take lorlatinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.
How fast does lorlatinib work?
Responses were rapid. The median time to first tumour response was just 1–4 months. Lorlatinib even maintains its clinical activity regardless of number of previous administrated TKIs. Here, we describe two cases with metastatic ALK-rearranged NSCLC who had pulmonary disease control with first-generation ALK inhibitor
Where can I buy Abacavir Sulfate Tablets?

You can buy Abacavir Sulfate Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Lotltinib Tablets?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Lotltinib  price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

Who developed Lorlatinib?
Lorlatinib is an oral small molecule inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1) kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer (NSCLC).

NEWS / UPDATES

  1. Pfizer Ltd, Electronic medicines compendium (emc), [Revised on March 2021] [ Accessed on 17th August 2021], https://www.medicines.org.uk/emc/files/pil.10632.pdf
  2. Pfizer, US Food and Drug Administration, [Revised on March 2021] [ Accessed on 17th August 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210868s004lbl.pdf
  3. Alice T Shaw et al; First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer; The New England Journal of Medicine; Published on 19/11/2020; Accessed on 17/08/2021; https://pubmed.ncbi.nlm.nih.gov/33207094